KK
PCRX icon

KLP Kapitalforvaltning’s Pacira BioSciences PCRX Stock Holding History

KLP Kapitalforvaltning’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
63,000
+29,700
+89% +$702K 0.01% 892
2026
Q1 		$753K Hold
33,300
– – ﹤0.01% 1189
2025
Q4 		$862K Sell
33,300
-14,600
-30% -$347K ﹤0.01% 1111
2025
Q3 		$1.23M Buy
47,900
+12,700
+36% +$312K ﹤0.01% 916
2025
Q2 		$841K Buy
35,200
+11,500
+49% +$290K ﹤0.01% 1076
2025
Q1 		$589K Hold
23,700
– – ﹤0.01% 1213
2024
Q4 		$447K Buy
+23,700
New +$416K ﹤0.01% 1445

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's PCRX Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Pacira BioSciences (PCRX) stake by 89% in Q2 2026, buying an estimated $702K and bringing the position to 63,000 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #892.

KLP Kapitalforvaltning first reported a position in PCRX in Q4 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • KLP Kapitalforvaltning held 63,000 shares of Pacira BioSciences worth $1.6M as of Q2 2026.
  • KLP Kapitalforvaltning bought 29,700 Pacira BioSciences shares in Q2 2026, an estimated $702K.
  • Pacira BioSciences made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #892 holding.
  • KLP Kapitalforvaltning first reported a position in Pacira BioSciences in Q4 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.